The Pulmonary, Critical Care, and Sleep Medicine Section has strong nationally recognized research programs in lung diseases and critical care medicine.
The faculty performs wide spectrum of research activities including investigations into the molecular mechanisms of lung diseases and translational research studies as well as clinical trials. Laboratory and translational studies are conducted in state of the art laboratory facilities at Baylor College of Medicine. Clinical trials include Phase I, II and III studies and are conducted in various hospitals and clinics in the Texas Medical Center. The research in the section is supported by $4.8 million from federal and private research grants. Areas of active research in the section include investigation into the pathogenesis and potential novel therapeutic strategies for diseases such as asthma, chronic obstructive lung diseases, interstitial lung diseases, pulmonary hypertension, pulmonary fibrosis, lymphangioleiomyomatosis, transitional medicine, lung transplant, lung cancer, and cystic fibrosis.
Clinical Research Studies
Clinical trials- also known as clinical studies or research protocols – are conducted to test whether a new drug, new prevention, diagnostic strategy, or new screening test is safe and effective in people. Participation is always voluntary. The investigators in our section conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions. To find out more, visit links below for current trial details, eligibility criteria and contact information.
- Pulmonary Hypertension (for current recruiting studies please call: 713-798-2400)
- Pulmonary Fibrosis (for current recruiting studies please call: 713-798-2400)